Roberts, Glore & Co’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,478
| Closed | -$793K | – | 179 |
|
|
2020
Q1 | $793K | Sell |
4,478
-186
| -4% | -$32.9K | 0.34% | 73 |
|
|
2019
Q4 | $891K | Buy |
4,664
+2,470
| +113% | +$472K | 0.34% | 75 |
|
|
2019
Q3 | $369K | Sell |
2,194
-372
| -14% | -$62.6K | 0.23% | 96 |
|
|
2019
Q2 | $430K | Sell |
2,566
-690
| -21% | -$116K | 0.26% | 89 |
|
|
2019
Q1 | $477K | Sell |
3,256
-555
| -15% | -$81.3K | 0.3% | 83 |
|
|
2018
Q4 | $509K | Sell |
3,811
-403
| -10% | -$53.8K | 0.36% | 77 |
|
|
2018
Q3 | $803K | Buy |
4,214
+5
| +0.1% | +$953 | 0.46% | 69 |
|
|
2018
Q2 | $702K | Sell |
4,209
-465
| -10% | -$77.6K | 0.43% | 74 |
|
|
2018
Q1 | $787K | Buy |
4,674
+104
| +2% | +$17.5K | 0.49% | 60 |
|
|
2017
Q4 | $748K | Sell |
4,570
-2,473
| -35% | -$405K | 0.46% | 67 |
|
|
2017
Q3 | $1.44M | Sell |
7,043
-60
| -0.8% | -$12.3K | 0.93% | 32 |
|
|
2017
Q2 | $1.73M | Buy |
7,103
+75
| +1% | +$18.2K | 1.15% | 25 |
|
|
2017
Q1 | $1.68M | Sell |
7,028
-180
| -2% | -$43K | 1.16% | 24 |
|
|
2016
Q4 | $1.51M | Buy |
7,208
+830
| +13% | +$174K | 1.06% | 29 |
|
|
2016
Q3 | $1.47M | Buy |
6,378
+1,246
| +24% | +$287K | 1.06% | 29 |
|
|
2016
Q2 | $1.19M | Buy |
+5,132
| New | +$1.19M | 0.9% | 34 |
|